Moleculin Biotech
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MBRX and other ETFs, options, and stocks.About MBRX
Moleculin Biotech, Inc. is a clinical stage pharmaceutical company. It engages in the business of growing a pipeline including phase 2 clinical programs for hard-to-treat cancers and viruses.
CEOWalter V. Klemp
CEOWalter V. Klemp
Employees17
Employees17
HeadquartersHouston, Texas
HeadquartersHouston, Texas
Founded2015
Founded2015
Employees17
Employees17
MBRX Key Statistics
Market cap15.83M
Market cap15.83M
Price-Earnings ratio-0.13
Price-Earnings ratio-0.13
Dividend yield—
Dividend yield—
Average volume150.75K
Average volume150.75K
High today$7.75
High today$7.75
Low today$7.27
Low today$7.27
Open price$7.53
Open price$7.53
Volume126.99K
Volume126.99K
52 Week high$91.25
52 Week high$91.25
52 Week low$6.01
52 Week low$6.01
Stock Snapshot
The current Moleculin Biotech(MBRX) stock price is $7.69, with a market capitalization of 15.83M. The stock trades at a price-to-earnings (P/E) ratio of -0.13.
On 2025-12-04, Moleculin Biotech(MBRX) stock traded between a low of $7.27 and a high of $7.75. Shares are currently priced at $7.69, which is +5.8% above the low and -0.8% below the high.
The Moleculin Biotech(MBRX)'s current trading volume is 126.99K, compared to an average daily volume of 150.75K.
In the last year, Moleculin Biotech(MBRX) shares hit a 52-week high of $91.25 and a 52-week low of $6.01.
In the last year, Moleculin Biotech(MBRX) shares hit a 52-week high of $91.25 and a 52-week low of $6.01.
People also own
Based on the portfolios of people who own MBRX. This list is generated using Robinhood data, and it’s not a recommendation.